Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 44, 2015 - Issue 3
184
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Employing XIAP to Enhance the Duration of Antigen Expression and Immunity Against an Avian Influenza H5 DNA Vaccine

, , &

REFERENCES

  • Andrew ME, Coupar BE, Boyle DB, Ada GL. (1987). The roles of influenza virus haemagglutinin and nucleoprotein in protection: Analysis using vaccinia virus recombinants. Scand J Immunol, 25, 21–8
  • Azizi A, Aucoin S, Tadesse H, et al. (2005). A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses. Genet Vaccines Ther, 3, 7
  • Bauler LD, Duckett CS, O'Riordan MX. (2008). XIAP regulates cytosol-specific innate immunity to Listeria infection. PLoS Pathog, 4(8), 1–12
  • Bergmann-Leitner ES, Duncan EH, Leitner WW, et al. (2007). C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium berghei. Vaccine, 25, 7732–6
  • Bergmann-Leitner ES, Leitner WW, Duncan EH, et al. (2009). Molecular adjuvants for malaria DNA vaccines based on the modulation of host-cell apoptosis. Vaccine, 27, 5700–8
  • Bower JF, Ross TM. (2006). A minimum CR2 binding domain of C3d enhances immunity following vaccination. Adv Exp Med Biol, 586, 249–64
  • Braciale TJ, Braciale VL, Winkler M, et al. (1987). On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes. J Exp Med, 166, 678–92
  • Conte D, Liston P, Wong JW, et al. (2001). Thymocyte-targeted overexpression of xiap transgene disrupts T lymphoid apoptosis and maturation. Proc Natl Acad Sci USA, 98, 5049–54
  • Dai J, Pei D, Wang B, et al. (2013). A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureus. Virol J, 10, 40–52
  • Davis HL, Millan CL, Watkins SC. (1997). Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther, 4, 181–8
  • Deveraux QL, Roy N, Stennicke HR, et al. (1998). IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J, 17, 2215–23
  • Deveraux QL, Takahashi R, Salvesen GS, Reed JC. (1997). X-linked IAP is a direct inhibitor of cell-death proteases. Nature, 388, 300–4
  • Flory E, Kunz M, Scheller C, et al. (2000). Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase. J Biol Chem, 275, 8307–14
  • Geiben-Lynn R, Greenland JR, Frimpong-Boateng K, et al. (2008). CD4+ T lymphocytes mediate in vivo clearance of plasmid DNA vaccine antigen expression and potentiate CD8+ T-cell immune responses. Blood, 112, 4585–90
  • Greenland JR, Geiben R, Ghosh S, et al. (2007). Plasmid DNA vaccine-elicited cellular immune responses limit in vivo vaccine antigen expression through Fas-mediated apoptosis. J Immunol, 178, 5652–8
  • Herfst S, Schrauwen EJ, Linster M, et al. (2012). Airborne transmission of influenza A/H5N1 virus between ferrets. Science, 336, 1534–41
  • Hofer-Warbinek R, Schmid JA, Stehlik C, et al. (2000). Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J Biol Chem, 275, 22064–8
  • Imai M, Watanabe T, Hatta M, et al. (2012). Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature, 486, 420–8
  • Kim JH, Jacob J. (2009). DNA vaccines against influenza viruses. Curr Top Microbiol Immunol, 333, 197–210
  • Kim TW, Hung CF, Ling M, et al. (2003). Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins. J Clin Invest, 112, 109–17
  • Kim TW, Hung CF, Zheng M, et al. (2004). A DNA vaccine co-expressing antigen and an anti-apoptotic molecule further enhances the antigen-specific CD8+ T-cell immune response. J Biomed Sci, 11, 493–9
  • Kutzler MA, Weiner DB. (2008). DNA vaccines: Ready for prime time? Nat Rev Genet, 9, 776–88
  • Kuwano K, Braciale TJ, Ennis FA. (1989). Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins. Viral Immunol, 2, 163–73
  • Lam WY, Tang JW, Yeung AC, et al. (2008). Avian influenza virus A/HK/483/97(H5N1) NS1 protein induces apoptosis in human airway epithelial cells. J Virol, 82, 2741–51
  • Lewis PJ, van Drunen Littel-van den H, Babiuk LA. (1999). Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J Virol, 73, 10214–23
  • Lowy RJ. (2003). Influenza virus induction of apoptosis by intrinsic and extrinsic mechanisms. Int Rev Immunol, 22, 425–49
  • Lu M, Lin SC, Huang Y, et al. (2007). XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol Cell, 26, 689–702
  • Ludwig S, Pleschka S, Planz O, Wolff T. (2006). Ringing the alarm bells: Signalling and apoptosis in influenza virus infected cells. Cell Microbiol, 8, 375–86
  • Octaviani CP, Ozawa M, Yamada S, et al. (2010). High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol, 84, 10918–22
  • Ogunremi O, Pasick J, Kobinger GP, et al. (2013). A single electroporation delivery of a DNA vaccine containing the hemagglutinin gene of Asian H5N1 avian influenza virus generated a protective antibody response in chickens against a North American virus strain. Clin Vaccine Immunol, 20, 491–500
  • Pahl HL, Baeuerle PA. (1995). Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B. J Virol, 69, 1480–4
  • Pence BD, Hester SN, Donovan SM, Woods JA. (2012). Dietary whole glucan particles do not affect antibody or cell-mediated immune responses to influenza virus vaccination in mice. Immunol Invest, 41, 275–89
  • Rao SS, Kong WP, Wei CJ, et al. (2010). Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret. PLoS One, 5, e9812
  • Rehm M, Huber HJ, Dussmann H, Prehn JH. (2006). Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein. EMBO J, 25, 4338–49
  • Rigaud S, Fondaneche MC, Lambert N, et al. (2006). XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature, 444, 110–14
  • Sanna MG, da Silva Correia J, Ducrey O, et al. (2002). IAP suppression of apoptosis involves distinct mechanisms: The TAK1/JNK1 signaling cascade and caspase inhibition. Mol Cell Biol, 22, 1754–66
  • Schultz-Cherry S, Dybdahl-Sissoko N, Neumann G, et al. (2001). Influenza virus ns1 protein induces apoptosis in cultured cells. J Virol, 75, 7875–81
  • Swayne DE, Kapczynski D. (2008). Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol Rev, 225, 314–31
  • Takahashi R, Deveraux Q, Tamm I, et al. (1998). A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem, 273, 7787–90
  • Tamm I, Kornblau SM, Segall H, et al. (2000). Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res, 6, 1796–803
  • Treanor J, Wright PF. (2003). Immune correlates of protection against influenza in the human challenge model. Dev Biol (Basel), 115, 97–104
  • Wiendl H, Hohlfeld R, Kieseier BC. (2005). Immunobiology of muscle: Advances in understanding an immunological microenvironment. Trends Immunol, 26, 373–80
  • Wilkinson JC, Cepero E, Boise LH, Duckett CS. (2004). Upstream regulatory role for XIAP in receptor-mediated apoptosis. Mol Cell Biol, 24, 7003–14
  • World Health Organization (WHO). (2015). Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO, 2003–2015. http://www.who.int/influenza/human_animal_interface/EN_GIP_20150106CumulativeNumberH5N1cases_corrected.pdf (accessed January 6, 2015)
  • Wurzer WJ, Ehrhardt C, Pleschka S, et al. (2004). NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation. J Biol Chem, 279, 30931–7
  • Xu L, Bao L, Li F, et al. (2014). Intranasal immunization of mice with inactivated virus and mast cell activator C48/80 elicits protective immunity against influenza H1 but not H5. Immunol Invest, 43, 224–35
  • Yamaguchi K, Nagai S, Ninomiya-Tsuji J, et al. (1999). XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J, 18, 179–87
  • Zamarin D, Garcia-Sastre A, Xiao X, et al. (2005). Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog, 1, e4
  • Zhang C, Yang Y, Zhou X, et al. (2010). Highly pathogenic avian influenza A virus H5N1 NS1 protein induces caspase-dependent apoptosis in human alveolar basal epithelial cells. Virol J, 7, 51–6
  • Zhou F, Wang G, Buchy P, et al. (2012). A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses. J Virol, 86, 6970–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.